Viet Nam Pharmaceutical - JSC (HSTC:DVN) Total Equity: ₫4,181,616 Mil (As of Mar. 2026)


HSTC:DVN Viet Nam Pharmaceutical Corp - JSC HSTC:DVN
79 GF Score
Price ₫20,000.00
GF Value ₫22,074.26
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Viet Nam Pharmaceutical - JSC Total Equity?

Viet Nam Pharmaceutical - JSC HSTC:DVN 79 Total Equity is ₫4,181,616 Mil as of Mar. 2026. GuruFocus rates HSTC:DVN with a GF Score™ of 79/100 and a GF Value™ of ₫22,074.26 (Fairly Valued). The stock has 5 warning signs investors should review.

Viet Nam Pharmaceutical - JSC's total equity for the quarter that ended in Mar. 2026 was ₫4,181,616 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.


Viet Nam Pharmaceutical - JSC Total Equity Historical Data

* Premium members only.

The historical data trend for Viet Nam Pharmaceutical - JSC's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Viet Nam Pharmaceutical - JSC Total Equity Chart

Viet Nam Pharmaceutical - JSC Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial 2,994,719.76 2,765,522.44 3,236,886.21 3,509,935.94 4,031,671.18

Viet Nam Pharmaceutical - JSC Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,592,697.79 3,479,607.26 3,574,013.83 4,031,671.18 4,181,615.80
HSTC:DVN
79GF Score
Viet Nam Pharmaceutical Corp - JSC HSTC:DVN
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Viet Nam Pharmaceutical - JSC Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Viet Nam Pharmaceutical - JSC's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=7652469.962-3620798.78
=4,031,671

Viet Nam Pharmaceutical - JSC's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=7750853.302-3569237.502
=4,181,616

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of ₫4,181,616 Mil mean?
Viet Nam Pharmaceutical - JSC (HSTC:DVN) has a Total Equity of ₫4,181,616 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Viet Nam Pharmaceutical - JSC and its competitors.
Is Viet Nam Pharmaceutical - JSC's Total Equity too high?
Viet Nam Pharmaceutical - JSC's current Total Equity is ₫4,181,616 Mil. Overall, Viet Nam Pharmaceutical - JSC has a GF Score™ of 79/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Viet Nam Pharmaceutical - JSC's Total Equity compare to ZTS and UTHR?
Viet Nam Pharmaceutical - JSC's Total Equity of ₫4,181,616 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Drug Manufacturers company?
A good Total Equity depends on the Drug Manufacturers industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Viet Nam Pharmaceutical - JSC and its competitors. Viet Nam Pharmaceutical - JSC's current Total Equity is ₫4,181,616 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Viet Nam Pharmaceutical - JSC stock overvalued right now?
Based on GuruFocus' analysis, Viet Nam Pharmaceutical - JSC (HSTC:DVN) is currently considered Fairly Valued. The stock's GF Value™ is ₫22,074.26, compared to a current price of ₫20,000.00 — trading 9.4% below its estimated fair value. The current Total Equity is ₫4,181,616 Mil. Viet Nam Pharmaceutical - JSC's overall GF Score™ is 79/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Viet Nam Pharmaceutical - JSC (HSTC:DVN), the current Total Equity is ₫4,181,616 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Viet Nam Pharmaceutical - JSC (HSTC:DVN) Overvalued in 2026?

Based on GuruFocus' analysis, Viet Nam Pharmaceutical - JSC stock appears to be undervalued. The current stock price of ₫20,000.00 is trading 9.4% below its estimated GF Value™ of ₫22,074.26. GuruFocus considers Viet Nam Pharmaceutical - JSC to be Fairly Valued.

Key valuation signals for HSTC:DVN:

  • Total Equity: ₫4,181,616 Mil
  • GF Value™: ₫22,074.26 vs. price of ₫20,000.00 (9.4% below fair value)
  • GF Score™: 79/100 with 5 warning signs

No single metric tells the full story. See the HSTC:DVN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Viet Nam Pharmaceutical - JSC Business Description

Address 12 Ngo Tat To, Van Mieu Ward, Dong Da District, Hanoi, VNM
Viet Nam Pharmaceutical Corp - JSC is engaged in the manufacturing of drugs. The company provides testing services for drugs and medicinal ingredients.
79GF Score

Get the complete analysis for HSTC:DVN

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₫20,000.00
Price
₫22,074.26
GF Value